Page last updated: 2024-08-17

galactose and oridonin

galactose has been researched along with oridonin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duan, C; Gao, J; Jia, L; Liu, G; Liu, Y; Tian, X; Wang, F; Zhang, D; Zhang, Q; Zheng, D1
Duan, C; Guo, H; Jia, L; Li, C; Liu, G; Liu, Y; Wang, F; Zhang, D; Zhang, Q; Zheng, D1
Guo, H; Hao, L; Li, C; Liu, G; Shen, J; Tian, X; Zhang, D; Zhang, Q; Zheng, D1
Cheng, H; Guo, H; Li, C; Liu, G; Liu, X; Wang, Y; Zhang, F; Zhang, Y; Zhao, Z1

Other Studies

4 other study(ies) available for galactose and oridonin

ArticleYear
Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin.
    Biomacromolecules, 2011, Dec-12, Volume: 12, Issue:12

    Topics: Acrylamides; Carcinoma, Hepatocellular; Chitosan; Diterpenes, Kaurane; Drug Carriers; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Nanogels; Polyethylene Glycols; Polyethyleneimine

2011
Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin.
    International journal of pharmaceutics, 2012, Oct-15, Volume: 436, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Area Under Curve; Chitosan; Diterpenes, Kaurane; Drug Carriers; Galactose; Hepatocytes; Mice; Nanoparticles; Rats; Rats, Sprague-Dawley; Tissue Distribution

2012
Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin.
    International journal of pharmaceutics, 2013, May-01, Volume: 448, Issue:1

    Topics: Antineoplastic Agents, Phytogenic; Calorimetry, Differential Scanning; Diterpenes, Kaurane; Drug Carriers; Drug Compounding; Drug Stability; Galactose; Liver; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Powder Diffraction; Serum Albumin, Bovine; X-Ray Diffraction

2013
Novel galactosylated biodegradable nanoparticles for hepatocyte-delivery of oridonin.
    International journal of pharmaceutics, 2016, Apr-11, Volume: 502, Issue:1-2

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Diterpenes, Kaurane; Drug Carriers; Drug Liberation; Galactose; Hep G2 Cells; Hepatocytes; Humans; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E

2016